반응식
[OH:1][N:2]=[C:3]([NH2:10])[C:4]1[CH:9]=[CH:8][CH:7]=[N:6][CH:5]=1.[F:11][C:12]1[CH:13]=[C:14]([CH:18]=[C:19]([F:21])[CH:20]=1)[C:15](O)=O.N>>[F:11][C:12]1[CH:13]=[C:14]([C:15]2[O:1][N:2]=[C:3]([C:4]3[CH:5]=[N:6][CH:7]=[CH:8][CH:9]=3)[N:10]=2)[CH:18]=[C:19]([F:21])[CH:20]=1참가 물질
4
실험 절차
The title compound was prepared according to the procedure of Example 8 using N′-hydroxynicotinimidamide (Aldrich) and 3,5-difluorobenzoic acid (Aldrich). 1H NMR (300 MHz, CD3OD) δ 7.37 (tt, J=9.0, 2.3 Hz, 1H), 7.65 (ddd, J=7.9, 5.0, 1.0 Hz, 1H), 7.82-7.91 (m, 2H), 8.56 (dt, J=7.9, 2.0 Hz, 1H), 8.75 (dd, J=4.8, 1.6 Hz, 1H), 9.30 (dd, J=2.0, 0.8 Hz, 1H) ppm; MS (DCI/NH3) m/z 260 (M+H)+.
출처 및 근거
- ORD 기록
- ord-fc2143c9b4b746b592ea9a1ff026b384
- 출처 데이터셋
- uspto-grants-2015_05
- 특허 번호
- US09040568B2
연결된 노트
불러오는 중…